1. Home
  2. OLMA vs INVH Comparison

OLMA vs INVH Comparison

Compare OLMA & INVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • INVH
  • Stock Information
  • Founded
  • OLMA 2006
  • INVH 2012
  • Country
  • OLMA United States
  • INVH United States
  • Employees
  • OLMA N/A
  • INVH N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • INVH Real Estate
  • Sector
  • OLMA Health Care
  • INVH Finance
  • Exchange
  • OLMA Nasdaq
  • INVH Nasdaq
  • Market Cap
  • OLMA 378.9M
  • INVH 18.5B
  • IPO Year
  • OLMA 2020
  • INVH 2017
  • Fundamental
  • Price
  • OLMA $7.89
  • INVH $29.52
  • Analyst Decision
  • OLMA Strong Buy
  • INVH Buy
  • Analyst Count
  • OLMA 5
  • INVH 16
  • Target Price
  • OLMA $24.00
  • INVH $36.91
  • AVG Volume (30 Days)
  • OLMA 1.0M
  • INVH 3.6M
  • Earning Date
  • OLMA 11-11-2025
  • INVH 10-29-2025
  • Dividend Yield
  • OLMA N/A
  • INVH 3.93%
  • EPS Growth
  • OLMA N/A
  • INVH 14.19
  • EPS
  • OLMA N/A
  • INVH 0.89
  • Revenue
  • OLMA N/A
  • INVH $2,647,487,000.00
  • Revenue This Year
  • OLMA N/A
  • INVH $5.42
  • Revenue Next Year
  • OLMA N/A
  • INVH $3.66
  • P/E Ratio
  • OLMA N/A
  • INVH $33.23
  • Revenue Growth
  • OLMA N/A
  • INVH 5.09
  • 52 Week Low
  • OLMA $2.86
  • INVH $29.37
  • 52 Week High
  • OLMA $13.93
  • INVH $37.24
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 66.97
  • INVH 38.42
  • Support Level
  • OLMA $7.49
  • INVH $29.91
  • Resistance Level
  • OLMA $8.25
  • INVH $30.65
  • Average True Range (ATR)
  • OLMA 0.66
  • INVH 0.53
  • MACD
  • OLMA 0.12
  • INVH -0.05
  • Stochastic Oscillator
  • OLMA 80.06
  • INVH 3.98

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About INVH Invitation Homes Inc.

Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with almost 70% of the portfolio in the Western U.S. and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.

Share on Social Networks: